These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18405540)

  • 1. [Use of neuromuscular blockers in the critical patient].
    Sandiumenge A; Anglés R; Martínez-Melgar JL; Torrado H;
    Med Intensiva; 2008 Feb; 32 Spec No. 1():69-76. PubMed ID: 18405540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sedation and paralysis.
    Piriyapatsom A; Bittner EA; Hines J; Schmidt UH
    Respir Care; 2013 Jun; 58(6):1024-37. PubMed ID: 23709198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current therapeutic uses, pharmacology, and clinical considerations of neuromuscular blocking agents for critically ill adults.
    Warr J; Thiboutot Z; Rose L; Mehta S; Burry LD
    Ann Pharmacother; 2011 Sep; 45(9):1116-26. PubMed ID: 21828347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of muscle relaxants in the intensive care unit.
    Sharpe MD
    Can J Anaesth; 1992 Nov; 39(9):949-62. PubMed ID: 1451224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complications associated with sedative and neuromuscular blocking drugs in critically ill patients.
    Prielipp RC; Coursin DB; Wood KE; Murray MJ
    Crit Care Clin; 1995 Oct; 11(4):983-1003. PubMed ID: 8535989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromuscular-blocking drugs. Use and misuse in the intensive care unit.
    Murphy GS; Vender JS
    Crit Care Clin; 2001 Oct; 17(4):925-42. PubMed ID: 11762268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromuscular blocking agents in the neurosurgical intensive care unit.
    Ohlinger MJ; Rhoney DH
    Surg Neurol; 1998 Feb; 49(2):217-21. PubMed ID: 9457275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of the muscle relaxant in the intensive care unit].
    Nakatsuka H; Shimizu K; Sato T
    Masui; 2008 Jul; 57(7):853-9. PubMed ID: 18649640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of neuromuscular blockade in the critically ill patient.
    Burry L; HoSang M; Hynes-Gay P
    Dynamics; 2001; 12(3):28-33; quiz 34-5. PubMed ID: 11982205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuromuscular blockers in surgery and intensive care, Part 2.
    McManus MC
    Am J Health Syst Pharm; 2001 Dec; 58(24):2381-95. PubMed ID: 11794954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Airway management of the critically ill patient: rapid-sequence intubation.
    Reynolds SF; Heffner J
    Chest; 2005 Apr; 127(4):1397-412. PubMed ID: 15821222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agreement between muscle movement and peripheral nerve stimulation in critically ill pediatric patients receiving neuromuscular blocking agents.
    Peña O; Prestjohn S; Guzzetta CE
    Heart Lung; 2000; 29(5):309-18. PubMed ID: 10986525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of neuromuscular blocking agents in the ICU: where are we now?
    Greenberg SB; Vender J
    Crit Care Med; 2013 May; 41(5):1332-44. PubMed ID: 23591211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticosteroids and neuromuscular blockers in development of critical illness neuromuscular abnormalities: A historical review.
    Wilcox SR
    J Crit Care; 2017 Feb; 37():149-155. PubMed ID: 27736708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sedative and neuromuscular blocking drug use in critically ill patients with head injuries.
    Prielipp RC; Coursin DB
    New Horiz; 1995 Aug; 3(3):456-68. PubMed ID: 7496755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuromuscular blocking agents in the management of respiratory failure. Indications and treatment guidelines.
    Sapirstein A; Hurford WE
    Crit Care Clin; 1994 Oct; 10(4):831-43. PubMed ID: 8000929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of neuromuscular blockade in the critically ill patient.
    Michaud D; Abbas M; Gélinas C
    Dynamics; 2002; 13(3):11. PubMed ID: 12640839
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient: 2016 update-executive summary.
    Murray MJ; DeBlock HF; Erstad BL; Gray AW; Jacobi J; Jordan CJ; McGee WT; McManus C; Meade MO; Nix SA; Patterson AJ; Sands K; Pino RM; Tescher AN; Arbour R; Rochwerg B; Murray CF; Mehta S
    Am J Health Syst Pharm; 2017 Jan; 74(2):76-78. PubMed ID: 28069681
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuromuscular blocking agents in the intensive care unit.
    Rodríguez-Blanco J; Rodríguez-Yanez T; Rodríguez-Blanco JD; Almanza-Hurtado AJ; Martínez-Ávila MC; Borré-Naranjo D; Acuña Caballero MC; Dueñas-Castell C
    J Int Med Res; 2022 Sep; 50(9):3000605221128148. PubMed ID: 36173012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of peripheral nerve stimulators to monitor patients with neuromuscular blockade in the ICU.
    Kleinpell R; Bedrosian C; McCormick L; Kremer M; Bujalski L; Bronsted R
    Am J Crit Care; 1996 Nov; 5(6):449-54. PubMed ID: 8922161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.